Form: 10-K

Annual report pursuant to Section 13 and 15(d)

March 7, 2019

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-214207) of our report dated March 7, 2019 included in this Annual Report on Form 10-K of HedgePath Pharmaceuticals, Inc. (the “Company”), relating to the balance sheets of the Company as of December 31, 2018 and 2017, and the related statements of operations, stockholders’ equity and cash flows for the years then ended.

/s/ Cherry Bekaert LLP

Tampa, Florida

March 7, 2019